Alternative mechanisms of miR-34a regulation in cancer
- PMID: 29022903
- PMCID: PMC5682661
- DOI: 10.1038/cddis.2017.495
Alternative mechanisms of miR-34a regulation in cancer
Erratum in
-
Correction Alternative mechanisms of miR-34a regulation in cancer.Cell Death Dis. 2018 Jul 16;9(8):783. doi: 10.1038/s41419-018-0833-1. Cell Death Dis. 2018. PMID: 30013025 Free PMC article.
Abstract
MicroRNA miR-34a is recognized as a master regulator of tumor suppression. The strategy of miR-34a replacement has been investigated in clinical trials as the first attempt of miRNA application in cancer treatment. However, emerging outcomes promote the re-evaluation of existing knowledge and urge the need for better understanding the complex biological role of miR-34a. The targets of miR-34a encompass numerous regulators of cancer cell proliferation, survival and resistance to therapy. MiR-34a expression is transcriptionally controlled by p53, a crucial tumor suppressor pathway, often disrupted in cancer. Moreover, miR-34a abundance is fine-tuned by context-dependent feedback loops. The function and effects of exogenously delivered or re-expressed miR-34a on the background of defective p53 therefore remain prominent issues in miR-34a based therapy. In this work, we review p53-independent mechanisms regulating the expression of miR-34a. Aside from molecules directly interacting with MIR34A promoter, processes affecting epigenetic regulation and miRNA maturation are discussed. Multiple mechanisms operate in the context of cancer-associated phenomena, such as aberrant oncogene signaling, EMT or inflammation. Since p53-dependent tumor-suppressive mechanisms are disturbed in a substantial proportion of malignancies, we summarize the effects of miR-34a modulation in cell and animal models in the clinically relevant context of disrupted or insufficient p53 function.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.Oncotarget. 2016 Aug 2;7(31):49611-49622. doi: 10.18632/oncotarget.10417. Oncotarget. 2016. PMID: 27391063 Free PMC article.
-
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.Cell Mol Gastroenterol Hepatol. 2020;10(2):391-418. doi: 10.1016/j.jcmgh.2020.04.002. Epub 2020 Apr 15. Cell Mol Gastroenterol Hepatol. 2020. PMID: 32304779 Free PMC article.
-
Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential.Int J Mol Sci. 2019 Feb 16;20(4):861. doi: 10.3390/ijms20040861. Int J Mol Sci. 2019. PMID: 30781524 Free PMC article. Review.
-
Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.BMC Cancer. 2016 Feb 15;16:102. doi: 10.1186/s12885-016-2135-2. BMC Cancer. 2016. PMID: 26879132 Free PMC article.
-
MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance.Curr Pharm Des. 2016;22(7):933-9. doi: 10.2174/1381612822666151209153729. Curr Pharm Des. 2016. PMID: 26648462 Review.
Cited by
-
Unraveling the Regulatory Role of HuR/microRNA Axis in Colorectal Cancer Tumorigenesis.Cancers (Basel). 2024 Sep 18;16(18):3183. doi: 10.3390/cancers16183183. Cancers (Basel). 2024. PMID: 39335155 Free PMC article. Review.
-
MicroRNA-34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis.Neuropathol Appl Neurobiol. 2021 Oct;47(6):796-811. doi: 10.1111/nan.12717. Epub 2021 Jun 14. Neuropathol Appl Neurobiol. 2021. PMID: 33942341 Free PMC article.
-
Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma.J Exp Clin Cancer Res. 2019 Nov 12;38(1):466. doi: 10.1186/s13046-019-1436-0. J Exp Clin Cancer Res. 2019. PMID: 31718694 Free PMC article.
-
The miR-34 family and its clinical significance in ovarian cancer.J Cancer. 2020 Jan 13;11(6):1446-1456. doi: 10.7150/jca.33831. eCollection 2020. J Cancer. 2020. PMID: 32047551 Free PMC article.
-
Downregulation of miR-34a promotes endothelial cell growth and suppresses apoptosis in atherosclerosis by regulating Bcl-2.Heart Vessels. 2018 Oct;33(10):1185-1194. doi: 10.1007/s00380-018-1169-6. Epub 2018 Apr 27. Heart Vessels. 2018. PMID: 29704100
References
-
- Wang L, Yu J, Xu J, Zheng C, Li X, Du J. The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues. Gene 2014; 554: 1–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous